Vicki Poole Hoffmann

Learn More
The aim of this 6-month observational study was to examine which clinical, eating- and lifestyle-related factors were associated with weight gain in patients initiating or switching to oral(More)
Weight loss has been reported in patients switching treatment from olanzapine (OLZ) in the standard oral tablet formulation to OLZ in the orally disintegrating tablet formulation. (de Haan et al.,(More)
The objective of this study was to determine if early changes in triglycerides and weight may be useful in predicting longer-term changes in weight and other metabolic parameters. Data were from(More)